MARC record from Internet Archive

LEADER: 05430cam 2200769 a 4500
001 ocm34473173
003 OCoLC
005 20200515022844.0
008 960311s1996 enka b 001 0 eng
010 $a 96013797
040 $aDNLM/DLC$beng$cDLC$dNLM$dC#P$dSQU$dBAKER$dNLGGC$dBTCTA$dYDXCP$dB9K$dGEBAY$dOCLCQ$dZWZ$dOCLCF$dOCLCO$dOCLCQ$dUKUOY$dOCLCQ
016 7 $a9603928$2DNLM
020 $a0471967122$q(hbk. ;$qacidfree paper)
020 $a9780471967125$q(hbk. ;$qacidfree paper)
035 $a(OCoLC)34473173
050 00 $aRC271.C5$bM843 1996
060 00 $a1997 D-592
060 10 $aQV 269$bM961 1996
082 00 $a616.99/4061$220
084 $a44.81$2bcl
245 00 $aMultidrug resistance in cancer cells :$bmolecular, biochemical, physiological, and biological aspects /$cedited by Sudhir Gupta and Takashi Tsuruo.
260 $aChichester ;$aNew York :$bJ. Wiley,$c℗♭1996.
300 $axii, 507 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $apt. 1. Characterization, expression and functions of transporters in MDR -- Sect. A. Molecular characterization of transporter genes -- Cloning and structure: function analysis of the mouse mdr gene family -- Functional and molecular characterization of the human multidrug transporter -- Regulation of MDR genes -- Cytogenetic manifestations of multidrug resistance -- Chromosomal and extrachromosomal localization of human MDR genes -- MRP, mode of action and role in MDR -- Role of LRP/major vault protein in multidrug resistance -- DNA topoisomerase I inhibitors and multidrug resistance -- The role of topoisomerase II in multidrug resistance -- Glutathione and glutathione-associated enzymes in multidrug resistance -- Oncogenes and tumor suppressor genes in multidrug resistance -- Drug sensitivity genes: identification and analysis using the genetic suppressor element approach -- Sect. B. Biochemical properties of multidrug-resistant cells -- Changes in membrane ionic conductances associated with multidrug resistance -- Identification and characterization of the drug-binding sites of P-glycoprotein -- Phosphorylation of proteins involved in multidrug resistance -- Protein kinase C and its isozymes in multidrug resistance -- Non-PKC kinases and multidrug resistance -- Sect. C. Expression of multidrug resistance gene and P-glycoprotein in normal tissues -- P-glycoprotein expression in normal hematopoietic progenitors and cells of the immune system -- Role of P-glycoprotein in the transport of hormones and peptides -- Role of P-glycoprotein in the blood-brain barrier -- Transport of P-glycoprotein-modifying agents by P-glycoprotein -- Mice with disrupted P-glycoprotein genes -- pt. 2. Reversal of multidrug resistance -- Sect. A. Strategies for modifying multidrug resistance -- Molecular pharmacology of reversal of multidrug resistance and its clinical implications -- Multidrug resistance-reversing agents for potential clinical use -- Cyclopsporins and related fungal products in the reversal of P-glycoprotein-mediated multidrug resistance -- Oligonucleotide modulation of multidrug resistance gene expression -- Application of the MDR1 gene for human gene therapy -- Sect. B. Clinical reversal of multidrug resistance -- Reversal of MDR in acute leukemia and non-hodgkin's lymphoma -- Prognostic significance and reversal of MDR in multiple myeloma -- Reversal of MDR in solid tumors.
650 0 $aDrug resistance in cancer cells.
650 0 $aMultidrug resistance.
650 12 $aDrug Resistance, Neoplasm.
650 12 $aDrug Resistance, Multiple$xphysiology.
650 22 $aCarrier Proteins$xphysiology.
650 22 $aTumor Cells, Cultured.
650 7 $aRe sistance aux me dicaments.$2fmesh
650 7 $aProte ines de transport$xPhysiologie.$2fmesh
650 7 $aCellules cance reuses en culture.$2fmesh
650 7 $aRe sistance aux me dicaments antine oplasiques.$2fmesh
650 7 $aDrug resistance in cancer cells.$2fast$0(OCoLC)fst00898703
650 7 $aMultidrug resistance.$2fast$0(OCoLC)fst01028879
650 17 $aKanker.$2gtt
650 17 $aGeneesmiddelenresistentie.$2gtt
650 7 $aCancer$xChimiothe rapie.$2ram
650 7 $aRe sistance multiple aux me dicaments.$2ram
650 7 $aCellules cance reuses$xRe sistance aux me dicaments.$2ram
650 07 $aKrebszelle.$2swd
650 07 $aArzneimittelresistenz.$2swd
650 07 $aAufsatzsammlung.$2swd
650 07 $aKrebs (Medizin)$2swd
650 07 $aCytostatikum.$2swd
650 07 $aMultidrug-Resistenz.$2swd
650 07 $aKongress.$2swd
700 1 $aGupta, Sudhir.
700 1 $aTsuruo, Takashi.
856 41 $3Table of contents$uhttp://catdir.loc.gov/catdir/toc/onix03/96013797.html
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/description/wiley032/96013797.html
938 $aBaker & Taylor$bBKTY$c400.00$d400.00$i0471967122$n0002845119$sactive
938 $aBaker and Taylor$bBTCP$n96013797
938 $aYBP Library Services$bYANK$n100068465
029 1 $aAU@$b000012242308
029 1 $aGEBAY$b2609195
029 1 $aNLGGC$b147276608
029 1 $aNLM$b9603928
029 1 $aNZ1$b4207854
029 1 $aYDXCP$b100068465
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 104 OTHER HOLDINGS